Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2

JCI Insight(2023)10.1172/jci.insight.170681Source: DataRank Database

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2 is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 4.69)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Kirsten Bentley ORCID,Ceri A. Fielding ORCID,Keeley M. Hatfield,Danielle P. Ings ORCID,Debbie O. A. Harnum ORCID

Live enrichment

PubMed:37338994 PMC:PMC10445686 OpenAlex:https://openalex.org/W4381431385

Canadian Institutes of Health Research

Grant: VR1 – 173202

Medical Research Council

Grant: MR/V028448/1,MR/S00971X/1

Wellcome Trust

Grant: 217065/Z/19/Z,102215/2/13/2

Medical Research Council

Grant: MC_PC_15018

Medical Research Council

Grant: MR/S00971X/1

The Role Of Antibody in Enabling Cell-mediated Control of HCMV Infection

Medical Research Council

Grant: MR/V000489/1

Medical Research Council

Grant: G9815508

Wellcome Trust

Grant: 102215

The Avon Longitudinal Study for Parents and Children: An international resource for population genomic and lifecourse epidemiology. Core programme support 2014-2019.

Wellcome Trust

Grant: 102215/2/13/2

Medical Research Council

Grant: MC_PC_20031

Medical Research Council

Grant: MR/P001602/1

National Institute for Health Research (NIHR)

Grant: NIHR205029

Wellcome Trust

Grant: 217065/Z/19/Z

Health and Care Research Wales

Grant: HS-22-32

Medical Research Council

Grant: MC_PC_19009

Medical Research Council

Grant: MR/V028448/1

A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium

Medical Research Council

Grant: MC_PC_20060

Wellcome Trust

Grant: 217065

The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi-generation, longitudinal resource focusing on life course health and well-being.

Canadian Institutes of Health Research

Grant: unidentified

unidentified

Wellcome Trust

FWCI

4.69

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1172/jci.insight.170681

publisherhttps://doi.org/10.1172/jci.insight.170681

publisherhttps://insight.jci.org/articles/view/170681/files/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37338994

repositoryhttps://orca.cardiff.ac.uk/id/eprint/161770/1/170681.2-20230724033218-covered-e0fd13ba177f913fd3156f593ead4cfd.pdf

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciencesHumansSARS-CoV-2COVID-19 VaccinesCOVID-19Antibody-Dependent Cell CytotoxicityImmunity, HumoralImmunoglobulin G

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAntibody-Dependent Cell CytotoxicityHumansImmunoglobulin GImmunity, Humoral

Keywords

Antibody-dependent cell-mediated cytotoxicityAntibodyImmunityVirologyEpitopeImmunologyBiologyImmune systemHumoral immunityVaccinationMonoclonal antibodyVaccinesImmunoglobulinsNK cellscellular immune response570COVID-19 VaccinesSARS-CoV-2RAntibody-Dependent Cell CytotoxicityCOVID-19Immunity, HumoralImmunoglobulin G616MedicineHumansResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2

FAIR Checklist

Authors (9)

Funding (21 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)